Log In
Print
BCIQ
Print
Print this Print this
 

CDX-301

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionFMS-like tyrosine kinase 3 ligand (FLT3LG) that is a growth factor for dendritic cells
Molecular Target FMS-like tyrosine kinase 3 ligand (FLT3LG)
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I/II
Standard Indication Transplant (unspecified)
Indication DetailsMobilize hematopoietic stem cells in transplant patients
Regulatory Designation

Partner

Celldex Therapeutics Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today